HIPK2 and Sepsis: Compared with that in the sepsis group, the 16-day survival rate of the Ad-HIPK2-treated sepsis group was improved (p < 0.05) (Fig. 2c), indicating that the pretreatment of mice with Ad-HIPK2 before CLP significantly decreased lethality compared to that in animals with CLP-induced sepsis.